Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? (Q38500120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

review article

1 reference

title

Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

G Targher

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Rossini

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

24 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

817-825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40618-015-0315-6

15 February 2020

exact match

0 references

cites work

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Extrahepatic complications of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

CKD and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Novel insights into the relationship between diabetes and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Negative association between trunk fat, insulin resistance and skeleton in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Inflammatory bone loss: pathogenesis and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Acidic bone matrix proteins and their roles in calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Bone: from a reservoir of minerals to a regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Pathophysiological roles of osteoprotegerin (OPG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Osteoprotegerin and diabetes-associated pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Leptin in nonalcoholic fatty liver disease: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Leptin may play a role in bone microstructural alterations in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Emerging molecular targets for the treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

In vitro and in vivo effects of adiponectin on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Vitamin D, thrombosis, and hemostasis: more than skin deep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Associations between objectively-measured sedentary behaviour and physical activity with bone mineral density in adults and older adults, the NHANES study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Hepatic osteodystrophy is common in patients with noncholestatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

The risk of fractures among patients with cirrhosis or chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Testosterone in men with advanced liver disease: abnormalities and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Effects of the gut microbiota on bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

The Gordian Knot of dysbiosis, obesity and NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

FXR signaling in the enterohepatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Bile acids as metabolic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Vitamin D Deficiency Is Associated With Inflammation in Older Irish Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Tumor necrosis factor-? mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0315-6

Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

21 January 2018

1 reference

12 December 2020

Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis

1 reference

12 December 2020

Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease

1 reference

12 December 2020

Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration

1 reference

12 December 2020

Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway

1 reference

12 December 2020

Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand

1 reference

12 December 2020

Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.

1 reference

12 December 2020

The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival

1 reference

12 December 2020

Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages

1 reference

12 December 2020

The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

12 December 2020

Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease

1 reference

12 December 2020

Osteocalcin is a stress-responsive neuropeptide.

1 reference

12 December 2020

Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men

1 reference

12 December 2020

10.1007/S40618-015-0315-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26003827%20AND%20SRC:MED&resulttype=core&format=json